eli lilly compounded tirzepatide FDA says shortage is over after taking a second look Lilly Update on Mounjaro® and

Whether its dance classes or weightlifting, well help you find your groove

The article says semaglutide activates GLP-1 receptors throughout the digestive tract, not only the stomach, slowing the movement of food into the small intestine and reducing intestinal motility overall

To view or add a comment, sign in FDA approves Ionis Tryngolza for severe hypertriglyceridaemia The FDA approved Tryngolza for adults with severe hypertriglyceridaemia to reduce triglycerides and the risk of acute pancreatitis

The peptides ability to cross the blood-brain barrier indicates broad neurological activity

Evidence gaps and future directions What we still need: larger, longer human trials that standardize fiber types and doses

Download the report to discover: Market Opportunity: How GLP-1 is reshaping expectations around muscle health and longevity